Zhong Jun, Xia Lei, Dou Ning-Ning, Ying Ting-Ting, Zhu Jin, Liu Ming-Xing, Li Shi-Ting
Department of Neurosurgery, XinHua Hospital (The Cranial Nerve Disease Center of Shanghai), Shanghai JiaoTong University School of Medicine, Shanghai, 200092, China,
Acta Neurochir (Wien). 2015 Jan;157(1):93-8; discussion 98-9. doi: 10.1007/s00701-014-2247-x. Epub 2014 Oct 9.
Although microvascular decompression (MVD) surgery has been widely accepted as an effective treatment for hemifacial spasm (HFS), delayed relief cases have been frequently reported. Therefore, the value of an immediate redo MVD should be discussed.
This study included 1,435 HFS patients who underwent MVD with intraoperative abnormal muscle response (AMR) monitoring from 2011 through 2013 at XinHua Hospital. These cases were analyzed retrospectively with emphasis on the postoperative outcomes and introaperative findings.
After MVD, 1,384 HFS patients obtained relief immediately. The 51 unrelieved patients underwent AMR monitoring again the next day; this was positive in 48 and negative in 3 patients. These three patients with negative AMR obtained relief spontaneously within a week. Among the 48 positive patients, 31 and 11 were underwent redo MVD within a week and 5-22 months, respectively, and all achieved relief after the second operation. Of the six remainig patients, two obtained relief within 2 months and 4 remained unchanged in the up-to-3-year's follow-up period. In redo MVDs, insufficient decompression of the facial nerve accounted for the failure. Finally, in this database, the immediate postoperative cure rate was 96.4 %; with earlier redo MVD, the final cure rate could be increased to 99.9 %.
Despite being a reasonable remedy for HFS in the hands of an experienced neurosurgeon, sometimes small vessels can be missed while managing the main offending arteries during MVDs, which might account for the delayed relief. Therefore, reexamination of the AMR is necessary for unimproved patients; if a positive result is recorded, an immediate redo MVD is suggested.
尽管微血管减压术(MVD)已被广泛认为是治疗面肌痉挛(HFS)的有效方法,但仍有不少关于延迟缓解的病例报道。因此,应探讨即刻再次进行MVD的价值。
本研究纳入了2011年至2013年在新华医院接受MVD并术中进行异常肌肉反应(AMR)监测的1435例HFS患者。对这些病例进行回顾性分析,重点关注术后结果和术中发现。
MVD术后,1384例HFS患者即刻获得缓解。51例未缓解的患者于次日再次进行AMR监测,其中48例为阳性,3例为阴性。这3例AMR阴性的患者在一周内自行缓解。在48例阳性患者中,分别有31例和11例在一周内和5至22个月内接受了再次MVD手术,二次手术后均获得缓解。其余6例患者中,2例在2个月内获得缓解,4例在长达3年的随访期内无变化。在再次MVD手术中,面神经减压不充分是导致手术失败的原因。最终,在该数据库中,术后即刻治愈率为96.4%;早期进行再次MVD,最终治愈率可提高至99.9%。
尽管对于经验丰富的神经外科医生来说,MVD是治疗HFS的合理方法,但在MVD手术中处理主要责任动脉时,有时可能会遗漏小血管,这可能是导致延迟缓解的原因。因此,对于未改善的患者,有必要重新检查AMR;如果结果为阳性,建议即刻再次进行MVD手术。